Two Sigma Impact Appoints Dr. David Wennberg as an Executive Advisor

Dr. Wennberg to help support and grow Two Sigma Impact’s healthcare investing efforts.

NEW YORK—January 26, 2022—Two Sigma Impact, the impact investing business of Two Sigma, today announced that David Wennberg, MD, MPH, will serve as an Executive Advisor to support its healthcare investing efforts. In this role, Dr. Wennberg will source potential new investments and work with portfolio company management teams across the healthcare services industry but with a particular focus on tech-enabled behavioral health companies.

Dr. Wennberg has dedicated his nearly 30-year career to advancing innovations in healthcare, most recently as CEO of mental healthcare platform Quartet where he also served as chief data scientist. Dr. Wennberg’s experience and expertise in data science and healthcare technology will help Two Sigma Impact identify investment opportunities and support technology-driven companies within the growing behavioral health space.

“David’s background will help to augment our efforts to build technology solutions into the operating models of our healthcare investments as a way to drive both positive clinical outcomes and strong business performance,” said Geoff Lieberthal, Partner at Two Sigma Impact. “We are thrilled to partner with David whose deep expertise in data science, value-based contracting, tech-enabled healthcare delivery and mental health services will help us continue to source attractive investment opportunities and create meaningful impact at our portfolio companies.”

“As I’ve gotten to know Two Sigma Impact, I’ve been impressed with its thesis-driven approach to investing and its focus on bringing meaningful technological advancements to its portfolio companies,” Dr. Wennberg said. “The delivery of world class healthcare services is a labor intensive effort and Two Sigma Impact’s singular focus on creating good jobs and unlocking human potential can help its portfolio companies seek to become the employer of choice in their respective industries. I’m excited to join such a forward-looking team.”

Prior to Quartet Health, Dr. Wennberg held the role of CEO at the Northern New England Accountable Care Collaborative (NNEACC) and the High Value Health Collaborative at The Dartmouth Institute. He is also co-founder of Health Dialog Analytic Solutions, the analytic division of Health Dialog. He currently sits on the boards of SchoolCare and Pyramid Healthcare.

Two Sigma Impact is focused on investing in several sectors within healthcare including outpatient mental health, substance use disorder treatment and pediatric therapy. Two Sigma Impact has made two healthcare focused investments including Circle of Care, a leading home and clinic-based pediatric therapy provider based in Texas, and Community Medical Services, a high growth and market-leading Opioid Treatment Program provider.

About Two Sigma Impact

Two Sigma Impact is a business of Two Sigma. Its mission is to combine active, principled ownership and data science with the goal of achieving superior returns and positive social outcomes. The Two Sigma Impact team is focused on workforce impact – where they anticipate innovative and thoughtful investments in humans will lead to an enhanced employee experience, productivity, and long-term financial returns. As part of Two Sigma, Two Sigma Impact has access to expertise in data science, technology, and a range of corporate specialties, and seeks to support its portfolio companies with those resources.

Read more from Impact

This article is not an endorsement by Two Sigma of the papers discussed, their viewpoints or the companies discussed. The views expressed above reflect those of the authors and are not necessarily the views of Two Sigma Investments, LP or any of its affiliates (collectively, “Two Sigma”). The information presented above is only for informational and educational purposes and is not an offer to sell or the solicitation of an offer to buy any securities or other instruments. Additionally, the above information is not intended to provide, and should not be relied upon for investment, accounting, legal or tax advice. Two Sigma makes no representations, express or implied, regarding the accuracy or completeness of this information, and the reader accepts all risks in relying on the above information for any purpose whatsoever. Click here for other important disclaimers and disclosures.